Product
Trimetazidine
4 clinical trials
6 indications
Indication
Nonalcoholic Fatty Liver DiseaseIndication
Amyotrophic lateral sclerosisIndication
Motor Neuron DiseaseIndication
Transthyretin Amyloid CardiopathyIndication
Mitochondrial PathologyClinical trial
Evaluation of Potential Benefits of Trimetazidine in the Management of Pateints With Metabolic Associated Fatty Liver Disease ( MAFLD)Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Targeting Metabolic Flexibility in ALS (MetFlex); Safety and Tolerability of Trimetazidine for the Treatment of ALSStatus: Completed, Estimated PCD: 2023-05-24
Clinical trial
The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac AmyloidosisStatus: Completed, Estimated PCD: 2023-06-01
Clinical trial
Evaluation of Trimetazidine in Alleviating Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer PatientsStatus: Not yet recruiting, Estimated PCD: 2024-11-01